Cell Biotech Co., Ltd. (KOSDAQ:049960)
13,780
-20 (-0.14%)
Feb 21, 2025, 9:00 AM KST
Cell Biotech Revenue
Cell Biotech had revenue of 12.16B KRW in the quarter ending September 30, 2024, a decrease of -10.96%. This brings the company's revenue in the last twelve months to 52.60B, down -0.29% year-over-year. In the year 2023, Cell Biotech had annual revenue of 53.79B with 6.46% growth.
Revenue (ttm)
52.60B
Revenue Growth
-0.29%
P/S Ratio
1.80
Revenue / Employee
473.87M
Employees
111
Market Cap
94.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
Dec 31, 2020 | 45.58B | -377.42M | -0.82% |
Dec 31, 2019 | 45.96B | -16.58B | -26.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |